News & Analysis on Clinical Trial Services & Contract Research And Development
Determined to focus on its fuels and lubricant additives business, specialty chemical firm Lubrizol has sold its active pharmaceutical ingredient (API) and intermediate compounds division to Auctus, a German private equity firm.
The groundbreaking approval of Exubera signals that exciting times are ahead for the pulmonary route of drug delivery in many disease areas.
British drug delivery firm Vectura has inked a deal with Boehringer Ingelheim to develop a dry powder inhaler (DPI) for a range of proprietary respiratory products of the German company, intensifying competition in a burgeoning asthma market.
GlaxoSmithKline (GSK) has begun distributing Trizivir tagged with radio frequency identification (RFID) technology as it intensifies efforts to combat counterfeiting.
Silicone product provider Busak and Shamban, showcased a variety of solutions at this year's Interphex event, highlighting the stringent demands made by the pharma industry are met by its range of sealing and bearing products.